Tenderwize
Wróć do wyszukiwania

Pharmaceuticals with active substance Erythropoietin (ATC: B03XA01 - strength over 10,000 IU per dosage unit)

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline Aug 30, 2026 · 7 days left·Open·Supplies
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Erythropoietin (ATC: B03XA01 - in der Wirkstärke über 10.000 IE je Dosiereinheit)

70/100

Ocena szansy

PromisingLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

70 / 100

Złożoność

20 / 100

Czynniki ryzyka

AOK may terminate agreements early if exclusive contracts are tendered for the same active substance during the contrac...

No guaranteed volume; actual sales depend on prescription behavior and number of participants.

Submission deadline in 7 days

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Strong opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Supply of Erythropoietin pharmaceuticals (ATC B03XA01, >10,000 IU per dose unit) under non-exclusive discount agreements.
  • Open-house model allowing any eligible pharmaceutical company to participate at any time.
Pokaż pełne podsumowanie

This is an open-house model for non-exclusive discount agreements on Erythropoietin pharmaceuticals (strength >10,000 IU per dose unit) with AOK Sachsen-Anhalt. Any eligible pharmaceutical company can conclude a contract at any time under uniform conditions. The contract runs from earliest 01.11.2024 to 31.10.2026 (max 24 months). No estimated value or guaranteed volume is provided. The tender is not a public procurement under GWB but published for transparency.

Ryzyka

AOK may terminate agreements early if exclusive contracts are tendered for the same active substance during the contrac...

No guaranteed volume; actual sales depend on prescription behavior and number of participants.

Submission deadline in 7 days

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Must be a pharmaceutical company or consortium of pharmaceutical companies.

Administrative

  • Must request and submit completed participation documents and signed contract.
  • Must meet uniform contract conditions (not specified in detail).

Kryteria udzielenia

Lot 1

No competitive award; contract available to all eligible participants.

Zamawiający

Lokalizacja

Magdeburg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE258393558

Działalność

Health

Części (1)

LOT-0001

Pharmaceuticals with active substance Erythropoietin (ATC: B03XA01 - strength over 10,000 IU per dosage unit)

Conclusion of non-exclusive discount agreements for finished medicinal products containing Erythropoietin (ATC: B03XA01, strength >10,000 IU) under an open-house model. Any eligible pharmaceutical company can join at any time with standard contract terms. No exclusivity.

SuppliesEU fundedElectronic submission

Lokalizacja

DEE03, Germany

Czas trwania

2 YEAR

Kategoria

Pharmaceutical products

Kryteria udzielenia

No competitive award; contract available to all eligible participants.

Termin

Deadline Aug 30, 2026

Szczegóły zamówienia

Data publikacji
19 Sep 2024
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
567828-2024

Dokumenty (1)

Podobne przetargi